Intelligence · Clinical Development
Pipeline search results
Programs matching “advanced-solid-tumors” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 61 pipeline programs matching "advanced-solid-tumors" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
PRT543
Prelude Therapeutics Inc
Relapsed/Refractory Advanced Solid Tumors
1 trial -
Pevonedistat
Takeda
Advanced Solid Tumors, Neoplasms, Advanced Solid
1 trial -
RAD 001 in combination with Caelyx
BRIGHT MINDS BIOSCIENCES INC.
Advanced Solid Tumors
1 trial -
SKSD00702
BRIGHT MINDS BIOSCIENCES INC.
Advanced Solid Tumors
1 trial -
SSGJ-706
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Advanced Solid Tumors Patients
1 trial -
Satraplatin in combo with vinorelbine
BRIGHT MINDS BIOSCIENCES INC.
Advanced Solid Tumors
1 trial -
TEV-56278
Teva Pharma GmbH
Advanced Solid Tumors
1 trial -
ZIO-101-C (Darinaparsin)
Alaunos Therapeutics
Advanced Solid Tumors
1 trial -
[^14C]-alisertib
Takeda
Advanced Solid Tumors
1 trial -
darinaparsin
Alaunos Therapeutics
Advanced Solid Tumors
1 trial -
palifosfamide-tris
Alaunos Therapeutics
Advanced Solid Tumors
1 trial -
zimberelimab
Arcus Biosciences
Advanced Solid Tumors
1 trial -
Peginterferon α-2b plus an anti-PD-1
The First People's Hospital of Lianyungang
Advanced Solid Tumors
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.